HIF1A and pulmonary arterial hypertension: ZFC3H1 promotes the expression of BRD4 and HIF1a in PASMC, and its inhibition leads to the down-regulation of BRD4 and HIF1a and the reversal of the PAH phenotype in a murine model of pulmonary hypertension.